HCW Biologics HCWB
NASDAQ HCWB
$1.16 -0.01 (-0.85%)
At close: Oct 21, 2026 · 4:00 PM EDT

HCW Biologics (HCWB) Non-Current Debt (2024 - 2025)

Updated

HCW Biologics' Non-Current Debt was -$32,847 in Q4 2025, compared with -$31,010 a year earlier.

Analysis

HCW Biologics (HCWB) Non-Current Debt (2024 - 2025) Analysis & Trends

For FY2025, Non-Current Debt at HCW Biologics came in at -$127,623.

  • In earlier years, Non-Current Debt was -$119,398 in FY2024 and -$38,273 in FY2023.
  • The Q4 2025 figure marks the lowest quarterly Non-Current Debt in data going back to Q3 2023.
  • Per Business Quant data, HCWB's Non-Current Debt in the three quarters before Q4 2025 was -$31,391 (Q3 2025), -$30,925 (Q2 2025) and -$32,460 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 62.48 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 60.50 Bn
10 HCW Biologics 1.53 Mn -4.70 Mn -93,887.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 150,000.00
Dec 31, 2024 375,000.00
Sep 30, 2024 2.83 Mn
Jun 30, 2024 1.95 Mn
Mar 31, 2024 1.75 Mn
API Access

HCW Biologics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=HCWB&period=max&api_key=YOUR_API_KEY